Well-meaning advocates continue to propose importing medicine from foreign countries to lower drug prices for Americans. Past ...

Two Indian nationals were charged in connection with counterfeit Ozempic pens that spurred a December 2023 public warning from the FDA. According to court documents, from at least July 2023 to April ...

United States District Court Northern District of Indiana USA v Matthew Kawa, et al U.S. sentencing memo, Jennifer Stechkober Filed July 2026 Read the document.

United States District CourtNorthern District of Indiana USA v Matthew Kawa, et al U.S. sentencing memo, Matthew Kawa Filed July 2026 Read the document.

Document Tags: 3:25-cr-00091-CCB-SJF, PDL Indiana, PDL Matthew Kawa, PDL Paradigm Peptides, PDL Peptides, PDL research drugs, PDL smuggling, judgment Return to library United States District Court ...

United States District Court Northern District of Indiana USA v Matthew Kawa, et al Plea agreement, Jennifer Stechkober Filed October 2025 Read the document.

The Texas-based 503A compounding facility was warned for continuing to manufacture large amounts of weight loss drugs that are "essentially copies" of brand-name products, which is no longer permitted ...

The FDA has announced a third recall of compounded glutathione from Texas compounding pharmacies due to elevated endotoxin levels. Centric Compounding received nine reports of adverse events related ...

A UCLA Health review of 565 studies on six popular unapproved peptides— BPC-157, TB-500, CJC-1295, MK-677, ipamorelin and GHK-Cu—found little evidence that they provide meaningful benefits.

Past shortages of the blockbuster medications Ozempic, Mounjaro, Wegovy, and Zepbound triggered a surge in legitimately compounded, illegally compounded and black market GLP-1 sales. The supply gap ...